AXONICS R-SNM SYSTEM Trademark
Trademark Overview
On Wednesday, January 10, 2024, a trademark application was filed for AXONICS R-SNM SYSTEM with the United States Patent and Trademark Office. The USPTO has given the AXONICS R-SNM SYSTEM trademark a serial number of 98350548. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Thursday, November 14, 2024. This trademark is owned by Axonics, Inc.. The AXONICS R-SNM SYSTEM trademark is filed in the Medical Instrument Products category with the following description:
Nerve stimulator apparatus, namely, an external implantable pulse generator and internal implantable neurological lead for neurostimulation, as well as a charging system comprised primarily of a battery charger, patient remote control and physician programmer in the nature of downloadable communication software pre-programed by the manufacturer and downloadable control software pre-programed by the manufacturer that allows for direct communication between the patient and the system and/or the clinician and the system in order to configure or regulate the stimulation parameters for the implanted portion of the system, all sold together as a unit along with related system components comprised of surgical instrumentation, batteries, device display monitors, device display microprocessors, battery chargers and downloadable software pre-programed by the manufacturer for operating and programming the nerve stimulator apparatus
General Information
Serial Number | 98350548 |
Word Mark | AXONICS R-SNM SYSTEM |
Filing Date | Wednesday, January 10, 2024 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Thursday, November 14, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Pseudo Mark | AXONICS RSNM SYSTEM |
NOT AVAILABLE | system |
Goods and Services | Nerve stimulator apparatus, namely, an external implantable pulse generator and internal implantable neurological lead for neurostimulation, as well as a charging system comprised primarily of a battery charger, patient remote control and physician programmer in the nature of downloadable communication software pre-programed by the manufacturer and downloadable control software pre-programed by the manufacturer that allows for direct communication between the patient and the system and/or the clinician and the system in order to configure or regulate the stimulation parameters for the implanted portion of the system, all sold together as a unit along with related system components comprised of surgical instrumentation, batteries, device display monitors, device display microprocessors, battery chargers and downloadable software pre-programed by the manufacturer for operating and programming the nerve stimulator apparatus |
Classification Information
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, January 10, 2024 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | Axonics, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Irvine, CA 92618 |
Trademark Events
Event Date | Event Description |
Wednesday, January 10, 2024 | NEW APPLICATION ENTERED |
Monday, April 29, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, August 6, 2024 | ASSIGNED TO EXAMINER |
Thursday, August 15, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, August 15, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Thursday, August 15, 2024 | NON-FINAL ACTION E-MAILED |
Thursday, November 14, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, November 14, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, November 14, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |